4.5 Article

Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type

Journal

LUNG CANCER
Volume 63, Issue 2, Pages 235-240

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.lungcan.2008.04.017

Keywords

Lung adenocarcinoma; Epidermal growth factor receptor (EGFR); Gefitinib; Hobnail cell type; Micropapillary pattern

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology
  2. Japan Society for the Promotion of Science
  3. Ministry of Health, Labour and Welfare
  4. Smoking Research Foundation
  5. National Institute of Biomedical Innovation
  6. Vehicle Racing Commemorative Foundation

Ask authors/readers for more resources

The presence of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) mutations significantly correlates with tumor sensitivity to TK inhibitors, particularly in lung adenocarcinomas, the predominant histological subtype in Japan and the United States. To clarify links between EGFR mutations and pathological findings in Japanese lung cancer, detailed pathological features of adenocarcinomas were examined using the WHO criteria as well as our cell type classification (hobnail, columnar and polygonal). Medical records were reviewed for a total of 107 surgically resected tumors. Clinicopathological factors were examined and correlations with EGFR status were evaluated. EGFR mutations were found in 63 patients (59%) distributed through all four exons examined (through exons 18-21). EGFR mutations were significantly associated with female gender (P=0.003), non-smoker status (P=0.008) and hobnail cell morphology (P<0.00001). In addition, detailed pathological examination showed significant associations with bronchioloalveolar carcinoma (BAC) component and a micropapillary pattern (MPP) (P=0.012 and 0.043, respectively). We conclude that characteristic histological features, i.e. the hobnail cell morphology and the presence of BAC component and MPP are good predictors of EGFR mutations in lung adenocarcinoma. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available